- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02261168
Day-Night Rhythm in Human Skeletal Muscle
September 4, 2015 updated by: Maastricht University Medical Center
Day-night Rhythm in Human Skeletal Muscle Metabolism
This study evaluates the existence of a day-night rhythm in skeletal muscle energy metabolism in healthy lean subjects.
Subjects will stay at the research facility for 44 hours with a standardized living protocol during which several measurements of skeletal muscle and whole body energy metabolism will be performed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Recent evidence from both observational and experimental studies indicates that disobeying our normal day-night rhythm negatively influences our metabolic and cardiovascular health, possibly leading to obesity and type 2 diabetes mellitus (T2DM).
An important hallmark of obesity and T2DM is a decreased skeletal muscle mitochondrial function.
Interestingly, recent research indicates that also skeletal muscle mitochondrial function under the influence of a day-night rhythm.
The main objective of this study is to investigate the presence of a day-night rhythm in skeletal muscle energy metabolism (in particular mitochondrial function) of healthy young participants.
Therefore, subjects will stay at the research unit for 44 hours, with standardized meals and sleeping time.
During this period we will take five muscle biopsies, perform indirect calorimetry measurements and blood draws.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Maastricht, Netherlands
- Maastricht University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Caucasian
- Healthy (as determined by dependent physician based on medical questionnaire)
- Male
- Age: 18-35 years
- Normal BMI (18-25 kg/m2)
- Regular sleeping time (normally 7-9h daily)
Exclusion Criteria:
- Extreme early bird or extreme night person (score ≤30 or ≥70 on MEQ-SA questionnaire)
- Heavily varying sleep-wake rhythm
- Shiftwork during last 3 months
- Travel across >1 time zone in the last 3 months
- Engagement in exercise > 2 hours total per week
- Using >400mg caffeine daily
- Smoking
- Unstable body weight (weight gain or loss > 3kg in the last 3 months)
- Significant food allergies/intolerance (seriously hampering study meals)
- Participation in another biomedical study within 1 month before the first study visit
- Any contra-indication to Magnetic Resonance Imaging (MRI) scanning
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Standardized living protocol
Subjects are kept at the research facility to adhere to a standardized living protocol, mimicking a normal daily living situation.
During the study, multiple tests will be performed, including muscle biopsies, blood draws, MRS measurements and indirect calorimetry.
|
Subjects stay at the research facility for 44 hours and adhere to a standard sleeping, eating and activity protocol.
During this protocol, multiple measurements will be performed including skeletal muscle biopsies (m.
vastus lateralis), blood draws, indirect calorimetry and MRS measurements.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Day-night rhythm in skeletal muscle mitochondrial respiration
Time Frame: 40 hours.
|
O2-flux (pmol/mg/s) measured with high resolution respirometry upon administration of different substrates
|
40 hours.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Day-night rhythm in whole-body energy metabolism
Time Frame: 40 hours.
|
Energy expenditure (kJ/min), glucose oxidation (g/min) and fat oxidation (g/min) measured by indirect calorimetry
|
40 hours.
|
Day-night rhythm in muscle DNA, mRNA and protein levels of markers involved in molecular clock and mitochondrial metabolism.
Time Frame: 40 hours.
|
Quantify mRNA and protein levels by qPCR or micro-array and Western blots
|
40 hours.
|
Day-night rhythm of in markers of normal day-night rhythm (cortisol, melatonin, core body temperature)
Time Frame: measured during the 2nd study day
|
Blood cortisol and melatonin levels and core body temperature measured by an ingested telemetric pill.
|
measured during the 2nd study day
|
Day-night rhythm in blood metabolic compounds (e.g. glucose, insulin, FFA's, cholesterol)
Time Frame: measured during the 2nd study day
|
measured during the 2nd study day
|
|
Day-night rhythm of molecular clock mRNA and protein levels in blood PBMC's
Time Frame: measured during the 2nd study day
|
Measured by qPCR and Western Blots
|
measured during the 2nd study day
|
Change in liver volume and liver lipid concentration during the day
Time Frame: First study day 6 PM, second study day 7 AM
|
Measured by Magnetic Resonance Imaging and -Spectroscopy (MRI/MRS).
Lipid signals in the MRS spectra will be quantified while suppressing the strong water signal in the region of interest (right liver lobe)
|
First study day 6 PM, second study day 7 AM
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Patrick Schrauwen, PhD, Professor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
September 24, 2014
First Submitted That Met QC Criteria
October 6, 2014
First Posted (Estimate)
October 10, 2014
Study Record Updates
Last Update Posted (Estimate)
September 7, 2015
Last Update Submitted That Met QC Criteria
September 4, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- METC143027
- NL49363.068.14 (Registry Identifier: Toetsing Online)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
AstraZenecaRecruiting
Clinical Trials on Standardized living protocol
-
Maastricht UniversityMaastricht University Medical CenterCompletedDiabetes Mellitus, Type 2 | Insulin ResistanceNetherlands
-
Mackay Memorial HospitalNational Taiwan UniversityCompleted
-
Izmir Katip Celebi UniversityNot yet recruitingIdiopathic Pulmonary Fibrosis | Activity, Motor
-
University of California, San DiegoRady Children's Hospital, San DiegoRecruitingNeonatal Respiratory FailureUnited States
-
CAMC Health SystemUnknownAKI (Acute Kidney Injury) Due to TraumaUnited States
-
Riphah International UniversityHelping Hand Institute of Rehabilitation SciencesRecruiting
-
Riphah International UniversityCompletedPost-cardiac SurgeryPakistan
-
University Hospital Inselspital, BerneUniversity of BernCompletedNicotine DependenceSwitzerland
-
Universidad San JorgeMontpellier ClinicCompletedSubacromial ImpingementSpain
-
Laval UniversityMaltais, Francois, M.D.; Saey, Didier, M.D.; Dr Louis Laviolette; Dr Thomas SimilowskiUnknownChronic Obstructive Pulmonary DiseaseCanada